These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31021945)

  • 21. Long-acting reversible contraception: A route to reproductive justice or injustice.
    Kaitz M; Mankuta D; Mankuta L
    Infant Ment Health J; 2019 Sep; 40(5):673-689. PubMed ID: 31329311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'But you can't reverse a hysterectomy!' Perceptions of long acting reversible contraception (LARC) among young women aged 16-24 years: a qualitative study.
    Okpo E; Allerton L; Brechin S
    Public Health; 2014 Oct; 128(10):934-9. PubMed ID: 25369357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.
    Boulet SL; D'Angelo DV; Morrow B; Zapata L; Berry-Bibee E; Rivera M; Ellington S; Romero L; Lathrop E; Frey M; Williams T; Goldberg H; Warner L; Harrison L; Cox S; Pazol K; Barfield W; Jamieson DJ; Honein MA; Kroelinger CD
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):780-7. PubMed ID: 27490117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
    Eeckhaut MCW; Rendall MS; Zvavitch P
    Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting.
    Tibaijuka L; Odongo R; Welikhe E; Mukisa W; Kugonza L; Busingye I; Nabukalu P; Ngonzi J; Asiimwe SB; Bajunirwe F
    BMC Womens Health; 2017 Apr; 17(1):25. PubMed ID: 28376779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraception Practices Among Women on Opioid Agonist Therapy.
    Jia L; Norman WV
    J Obstet Gynaecol Can; 2021 Feb; 43(2):204-210. PubMed ID: 32980283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women's awareness of long-acting, reversible contraceptive methods (LARCs) in community family planning clinics and general practice.
    Mansour D; Rosales C; Cox M
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):396-9. PubMed ID: 19117255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy.
    Heil SH; Hand DJ; Sigmon SC; Badger GJ; Meyer MC; Higgins ST
    Prev Med; 2016 Nov; 92():62-67. PubMed ID: 27346756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S; Rajbhandary R; Lohani S
    Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating Pregnancy Ambivalence and Effectiveness in Contraceptive Choice.
    Sundstrom B; Ferrara M; DeMaria AL; Baker-Whitcomb A; Payne JB
    Health Commun; 2017 Jul; 32(7):820-827. PubMed ID: 27420543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's Awareness of, Interest in, and Experiences with Long-acting Reversible and Permanent Contraception.
    Burns B; Grindlay K; Dennis A
    Womens Health Issues; 2015; 25(3):224-31. PubMed ID: 25797219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
    Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
    Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new LNG-releasing IUS: a new opportunity to reduce the burden of unintended pregnancy.
    Cristobal I; Neyro JL; Lete I
    Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():58-64. PubMed ID: 25988513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.